Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment

Rheumatoid arthritis (RA) patients are at high risk of cardiovascular (CV) events, and the chronic inflammatory state may generate quantitative and qualitative changes in lipoprotein fractions. The anti-IL-6 receptor tocilizumab (TCZ), even if effective in inflammation and joint damage prevention, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacciapaglia, Fabio, Anelli, Maria Grazia, Rinaldi, Angela, Fornaro, Marco, Lopalco, Giuseppe, Scioscia, Crescenzio, Lapadula, Giovanni, Iannone, Florenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204176/
https://www.ncbi.nlm.nih.gov/pubmed/30405318
http://dx.doi.org/10.1155/2018/2453265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204176/
https://www.ncbi.nlm.nih.gov/pubmed/30405318
http://dx.doi.org/10.1155/2018/2453265

Ejemplares similares